BioLine RX Ltd (NASDAQ:BLRX)

4.05
Delayed Data
As of Jul 19
 +0.10 / +2.53%
Today’s Change
3.86
Today|||52-Week Range
27.60
-38.26%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 2
2018
Quarter 3
2018
Quarter 4
2018
Quarter 1
2019
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization146.8K125.9K130.1K213.8K
 
 
 
 
 
 
Operating ExpensesGross Income-146.8K-125.9K-130.1K-213.8K
 
 
 
 
 
General Expenses5.5M6.1M6.9M5.4M
 
 
 
 
 
Research And Development4.4M5.0M5.2M4.4M
 
 
 
 
 
Total Operating Expenses5.7M6.2M7.0M5.6M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-5.7M-6.2M-7.0M-5.6M
 
 
 
 
 
Interest Expense On Debt10.9K11.0K324.8K448.8K
 
 
 
 
 
Other Expenses657.6K-254.8K2.0M-341.4K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-4.7M-6.3M-5.6M-6.2M
 
 
 
 
 
Net Income-4.7M-6.3M-5.6M-6.2M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS7.1M7.1M7.6M133.0M
 
 
 
 
 
Shares To Calculate EPS Diluted7.1M7.1M7.6M133.0M
 
 
 
 
 
 
Earnings Per ShareEPS-$0.67-$0.88-$0.74-$0.05
 
 
 
 
 
EPS Diluted-$0.67-$0.88-$0.74-$0.05